The NSCLC with PIAS1-RASGRF1 was a squamous cell carcinoma, while HSPA4-RASGRF2 was identified in a large cell neuroendocrine carcinoma of the lung. This evidence concerns the gene HSPA4 and pulmonary large cell neuroendocrine carcinoma.